Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson…